Safety and Efficacy of Lidocaine Infiltration in Suction Assisted Lipectomy
1 other identifier
interventional
60
1 country
1
Brief Summary
RCT of S/E of lidocaine infiltration in tumescent technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 31, 2007
CompletedFirst Posted
Study publicly available on registry
January 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedJanuary 11, 2008
December 1, 2007
1 year
December 31, 2007
January 10, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain (VSA)
1, 6, 12, 18 and 24 post operative hours
Secondary Outcomes (2)
Rescue medication
1, 6, 12, 15 and 24 hours postoperative
Nausea, emesis, arrythmia, seizures, arrest, shock, death.
24 hours postoperative
Study Arms (2)
I
ACTIVE COMPARATORInfiltration with 0.9% saline+1:1,000,000 epinephrine+0.06% Lidocaine
II
PLACEBO COMPARATORInfiltration with 0.9% saline+1:1,000,000 epinephrine
Interventions
Subcutaneous infiltration with Active/Placebo solutions with tumescent technique previous to suction assisted lipectomy. Patient abdomen and back will be divided in 4 zones anterior and posterior, one side (left or right) will be infiltrated with active solution and the other with placebo. The allocation of the side will be made with random numbers.
Eligibility Criteria
You may qualify if:
- Woman
- I or II of the Classification of the American Society of Anesthesiologists.
- Completed high school.
- Between 18 and 40 years old
- At least suction of entire abdomen and back
- Body mass index between 20 and 27
- Accept written informed consent
You may not qualify if:
- Associated surgery
- Hypersensibility to (Cefazolin or Clindamycin, Lidocaine, Ketorolac, Morphine, Remifentanyl, Propofol, Tramadol).
- Pregnancy
- Previous surgery to abdominal wall or back, including cesarean.
- Abdominal wall hernia
- Previous liposuction
- Active psychosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Militar de Santiago
Santiago, RM, Chile
Related Publications (5)
Kaplan B, Moy RL. Comparison of room temperature and warmed local anesthetic solution for tumescent liposuction. A randomized double-blind study. Dermatol Surg. 1996 Aug;22(8):707-9. doi: 10.1111/j.1524-4725.1996.tb00621.x.
PMID: 8780763BACKGROUNDYang CH, Hsu HC, Shen SC, Juan WH, Hong HS, Chen CH. Warm and neutral tumescent anesthetic solutions are essential factors for a less painful injection. Dermatol Surg. 2006 Sep;32(9):1119-22; discussion 1123. doi: 10.1111/j.1524-4725.2006.32254.x.
PMID: 16970691BACKGROUNDRubin JP, Bierman C, Rosow CE, Arthur GR, Chang Y, Courtiss EH, May JW Jr. The tumescent technique: the effect of high tissue pressure and dilute epinephrine on absorption of lidocaine. Plast Reconstr Surg. 1999 Mar;103(3):990-6; discussion 997-1002.
PMID: 10077095BACKGROUNDRubin JP, Xie Z, Davidson C, Rosow CE, Chang Y, May JW Jr. Rapid absorption of tumescent lidocaine above the clavicles: a prospective clinical study. Plast Reconstr Surg. 2005 May;115(6):1744-51. doi: 10.1097/01.prs.0000161678.10555.53.
PMID: 15861085BACKGROUNDDanilla S, Fontbona M, de Valdes VD, Dagnino B, Sorolla JP, Israel G, Searle S, Norambuena H, Cabello R. Analgesic efficacy of lidocaine for suction-assisted lipectomy with tumescent technique under general anesthesia: a randomized, double-masked, controlled trial. Plast Reconstr Surg. 2013 Aug;132(2):327-332. doi: 10.1097/PRS.0b013e3182958b20.
PMID: 23897332DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Danilla, MD, MSc
Hospital Militar de Santiago
- STUDY CHAIR
Guillermo Israel, MD
Hospital Militar de Santiago
- STUDY CHAIR
Montserrat Fontbona, MD
Hospital Militar de Santiago
- STUDY DIRECTOR
Rodrigo Cabello, MD
Hospital Militar de Santiago
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 31, 2007
First Posted
January 11, 2008
Study Start
December 1, 2007
Primary Completion
December 1, 2008
Last Updated
January 11, 2008
Record last verified: 2007-12